Mast cells in inflammatory arthritis

Arthritis Research and Therapy

Volumn 7, Issue 1, 2005, Pages 1-11

  Nigrovic, Peter A ^a,b   Lee, David M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Inflammation; Mast cells; Rheumatoid arthritis; Synovitis; Synovium

Indexed keywords

AUTACOID; BASIC FIBROBLAST GROWTH FACTOR; CD48 ANTIGEN; CELL SURFACE RECEPTOR; CYTOKINE; GAMMA INTERFERON; GLUCOSE 6 PHOSPHATE ISOMERASE; HEPARIN; IMMUNOGLOBULIN E RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LEUKOTRIENE B4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN D2; RANTES; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ALLERGY; ARTHROPATHY; BACTERIAL INFECTION; CELL ACTIVATION; CELL FUNCTION; CELL POPULATION; CYTOKINE PRODUCTION; DISEASE MODEL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LEUKOCYTE; MAST CELL; MESENCHYME; MOUSE; NONHUMAN; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; CYTOKINES; CYTOPLASMIC GRANULES; EICOSANOIDS; GLUCOSE-6-PHOSPHATE ISOMERASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN E; INFLAMMATION; INFLAMMATION MEDIATORS; MAST CELLS; MESODERM; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ANTIGEN, T-CELL; SYNOVIAL MEMBRANE;

EID: 13444311883     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1446     Document Type: Review

References (115)

1. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB: Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692.
2. Corr M, Crain B: The role of FcγR signaling in the K/B x N serum transfer model of arthritis. J Immunol 2002, 169: 604-6669.
3. Metcalfe DD, Baram D, Mekori YA: Mast cells. Physiol Rev 1997, 77:1033-1079.
4. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991, 146:1410-1415.
5. Rodewald HR, Dessing M, Dvorak AM, Galli SJ: Identification of a committed precursor for the mast cell lineage. Science 1996, 271:818-822.
6. Galli SJ, Tsai M, Wershil BK: The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 1993, 142:965-974.
7. Juremalm M, Olsson N, Nilsson G: Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 2002, 297:480-485.
8. Wang HW, Tedla N, Lloyd AR, Wakefield D, McNeil PH: Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 1998, 102: 617-1626.
9. Friend DS, Gurish MF, Austen KF, Hunt J, Stevens RL: Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection. J Immunol 2000, 165:344-352.
10. Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, McCloskey N, Coker HA, Fear D, Smurthwaite L: The biology of IGE and the basis of allergic disease. Annu Rev Immunol 2003, 21:579-628.
11. Huang C, Friend DS, Qiu WT, Wong GW, Morales G, Hunt J, Stevens RL: Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J Immunol 1998, 160:1910-1919.
12. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990, 346:274-276.
13. Murakami M, Austen KF, Arm JP: The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through posttranslational activation of cytosolic phospholipase A2 and 5-lipoxygenase. J Exp Med 1995, 182:197-206.
14. King CL, Xianli J, Malhotra I, Liu S, Mahmoud AA, Oettgen HC: Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J Immunol 1997, 158:294-300.
15. Gurish MF, Bryce PJ, Tao H, Kisselgof AB, Thornton EM, Miller HR, Friend DS, Oettgen HC: IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J Immunol 2004, 172:1139-1145.
16. Galli SJ, Maurer M, Lantz CS: Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999, 11:53-59.
17. Echtenacher B, Mannel DN, Hultner L: Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75-77.
18. Malaviya R, Ikeda T, Ross E, Abraham SN: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996, 381:77-80.
19. Malaviya R, Ross EA, MacGregor JI, Ikeda T, Little JR, Jakschik BA, Abraham SN: Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 1994, 152:1907-1914.
20. Malaviya R, Abraham SN: Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol 2000, 67:841-846.
21. McCurdy JD, Olynych TJ, Maher LH, Marshall JS: Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003, 170:1625-1629.
22. Applequist SE, Wallin RP, Ljunggren HG: Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 2002, 14:1065-1074.
23. Malaviya R, Gao Z, Thankavel K, van der Merwe PA, Abraham SN: The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 1999, 96:8110-8115.
24. Kiener HP, Baghestanian M, Dominkus M, Walchshofer S, Ghannadan M, Willheim M, Sillaber C, Graninger WB, Smolen JS, Valent P: Expression of the C5a receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis. Arthritis Rheum 1998, 41: 33-245.
25. Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC: Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997, 390:172-175.
26. Dvorak AM, McLeod RS, Onderdonk A, Monahan-Earley RA, Cullen JB, Antonioli DA, Morgan E, Blair JE, Estrella P, Cisneros RL, et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol 1992, 99:74-83.
27. Malaviya R, Abraham SN: Mast cell modulation of immune responses to bacteria. Immunol Rev 2001, 179:16-24.
28. Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH: Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 2003, 4:965-973.
29. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD: Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 2003, 4:982-990.
30. + T cells through production of leukotriene B4. Nat Immunol 2003, 4:974-981.
31. Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD: Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 1996, 156: 1490-1496.
32. Bryce PJ, Miller ML, Miyajima I, Tsai M, Galli SJ, Oettgen HC: Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 2004, 20: -20.
33. McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, Gunn MD, Abraham SN: Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003, 4:1199-1205.
34. Okayama Y, Kirshenbaum AS, Metcalfe DD: Expression of a functional high-affinity IgG receptor, Fc gamma RI, on human mast cells: up-regulation by IFN-gamma. J Immunol 2000, 164:4332-4339.
35. Zhang Y, Ramos BF, Jakschik BA: Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992, 258:1957-1959.
36. Zhang Y, Ramos BF, Jakschik BA: Augmentation of reverse arthus reaction by mast cells in mice. J Clin Invest 1991, 88: 841-846.
37. Ramos BF, Zhang Y, Jakschik BA: Neutrophil elicitation in the reverse passive Arthus reaction. Complement-dependent and -independent mast cell involvement. J Immunol 1994, 152: 1380-1384.
38. Chen R, Ning G, Zhao ML, Fleming MG, Diaz LA, Werb Z, Liu Z: Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 2001, 108:1151-1158.
39. Liu Z, Giudice GJ, Swartz SJ, Fairley JA, Till GO, Troy JL, Diaz LA: The role of complement in experimental bullous pemphigoid. J Clin Invest 1995, 95:1539-1544.
40. Gordon JR, Galli SJ: Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated via the FcE RI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 1991, 174:103-107.
41. Xiang Z, Block M, Lofman C, Nilsson G: IgE-mediated mast cell degranulation and recovery monitored by time-lapse photography. J Allergy Clin Immunol 2001, 108:116-121.
42. Azizkhan RG, Azizkhan JC, Zetter BR, Folkman J: Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 1980, 152:931-944.
43. Nishida Y, Murase K, Isomoto H, Furusu H, Mizuta Y, Riddell RH, Kohno S: Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology 2002, 49: 678-682.
44. Boyce JA: The role of mast cells in asthma. Prostaglandins Leukot Essent Fatty Acids 2003, 69:195-205.
45. Seibold JR, Giorno RC, Claman HN: Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990, 33:1702-1709.
46. Pesci A, Bertorelli G, Gabrielli M, Olivieri D: Mast cells in fibrotic lung disorders. Chest 1993, 103:989-996,
47. Castor W: The microscopic structure of normal human synovial tissue. Arthritis Rheum 1960, 3:140-151.
48. Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM: Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 1984, 27:845-851.
49. Godfrey HP, Ilardi C, Engber W, Graziano FM: Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 1984, 27:852-856.
50. Gruber B, Poznansky M, Boss E, Partin J, Gorevic P, Kaplan AP: Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum 1986, 29: 944-955.
51. Malone DG, Wilder RL, Saavedra-Delgado AM, Metcalfe DD: Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum 1987, 30: 30-137.
52. Gotis-Graham I, Smith MD, Parker A, McNeil HP: Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann Rheum Dis 1998, 57:664-671.
53. Bromley M, Fisher WD, Woolley DE: Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis 1984, 43: 76-79.
54. Bromley M, Woolley DE: Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984, 27:857-863.
55. Tetlow LC, Woolley DE: Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis 1995, 54:549-555.
56. Partsch G, Schwagerl W, Eberl R: [Histamine in rheumatic diseases.] Z Rheumatol 1982, 41:19-22.
57. Frewin DB, Cleland LG, Jonsson JR, Robertson PW: Histamine levels in human synovial fluid. J Rheumatol 1986, 13: 3-14.
58. Malone DG, Irani AM, Schwartz LB, Barrett KE, Metcalfe DD: Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 1986, 29: 56-963.
59. Buckley MG, Walters C, Wong WM, Cawley MI, Ren S, Schwartz LB, Walls AF: Mast cell activation in arthritis: detection of α - and β-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin Sci (Lond) 1997, 93:363-370.
60. Lavery JP, Lisse JR: Preliminary study of the tryptase levels in the synovial fluid of patients with inflammatory arthritis. Ann Allergy 1994, 72:425-427.
61. Gotis-Graham I, McNeil HP: Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum 1997, 40: 479-489.
62. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST: Heterogeneity of human mast cells based on cytokine content. J Immunol 1995, 155:297-307.
63. McNeil HP, Gotis-Graham I: Human mast cell subsets - distinct functions in inflammation? Inflamm Res 2000, 49: -7.
64. Gryfe A, Sanders PM, Gardner DL: The mast cell in early rat adjuvant arthritis. Ann Rheum Dis 1971, 30:24-30.
65. MF van den Broek, WB van den Berg, LB van de Putte: The role of mast cells in antigen induced arthritis in mice. J Rheumatol 1988, 15:544-551.
66. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D: Organ-specific disease provoked by systemic autoimmunity. Cell 1996, 87:811-822.
67. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, Degott C, Kikutani H, Rajewsky K, Pasquali JL, et al.: From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999, 10:451-461.
68. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, et al.: Arthritis critically dependent on innate immune system players. Immunity 2002, 16:157-168.
69. Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, Gravallese E, Mathis D, Benoist C: Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med 2002, 196:77-85.
70. Maccioni M, Zeder-Lutz G, Huang H, Ebel C, Gerber P, Hergueux J, Marchal P, Duchatelle V, Degott C, van Regenmortel M, et al.: Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 2002, 195:1071-1077.
71. Ruddy S, Britton MC, Schur PH, Austen KF: Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis. Ann NY Acad Sci 1969, 168: 161-172.
72. Schur PH, Britton MC, Franco AE, Corson JM, Sosman JL, Ruddy S: Rheumatoid synovitis: complement and immune complexes. Rheumatology 1975, 6:34-42.
73. Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
74. Monach PA, Benoist C, Mathis D: The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol 2004, 82:217-248.
75. Pekin TJ Jr, Zvaifler NJ: Hemolytic complement in synovial fluid. J Clin Invest 1965, 43:1372-1382.
76. Johnson GB, Brunn GJ, Platt JL: Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol 2003, 23:15-44.
77. De Clerck LS, Struyf NJ, Bridts CH, Francx L, Van Offel JF, Empsten FA, Westedt ML, Breedveld FC, Cats A, Stevens WJ: Humoral immunity and composition of immune complexes in patients with rheumatoid arthritis, with special reference to IgE-containing immune complexes. Clin Exp Rheumatol 1989, 7:485-492.
78. Gruber B, Ballan D, Gorevic PD: IgE rheumatoid factors: quantification in synovial fluid and ability to induce synovial mast cell histamine release. Clin Exp Immunol 1988, 71:289-294.
79. Gaboury JP, Johnston B, Niu XF, Kubes P: Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol 1995, 154:804-813.
80. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF: Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991, 88:4220-4224.
81. Lawrence T, Willoughby DA, Gilroy DW: Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002, 2:787-795.
82. Dreher R: Origin of synovial type A cells during inflammation. An experimental approach. Immunobiology 1982, 161:232-245.
83. Hollywell C, Morris CJ, Farr M, Walton KW: Ultrastructure of synovial changes in rheumatoid disease and in seronegative inflammatory arthropathies. Virchows Arch A Pathol Anat Histopathol 1983, 400:345-355.
84. Ritchlin C: Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2000, 2:356-360.
85. Hamilton JA, Filonzi EL, lanches G: Regulation of macrophage colony-stimulating factor (M-CSF) production in cultured human synovial fibroblasts. Growth Factors 1993, 9:157-165.
86. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR: Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000, 43: 50-258.
87. Noli C, Miolo A: The mast cell in wound healing. Vet Dermatol 2001, 12:303-313.
88. Abe M, Kurosawa M, Ishikawa O, Miyachi Y: Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J Allergy Clin Immunol 2000, 106:S78-S84.
89. Gruber BL, Kew RR, Jelaska A, Marchese MJ, Garlick J, Ren S, Schwartz LB, Korn JH: Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1997, 158: 310-2317.
90. Jordana M, Befus AD, Newhouse MT, Bienenstock J, Gauldie J: Effect of histamine on proliferation of normal human adult lung fibroblasts. Thorax 1988, 43:552-558.
91. Li CY, Baek JY: Mastocytosis and fibrosis: role of cytokines. Int Arch Allergy Immunol 2002, 127:123-126.
92. Sempowski GD, Beckmann MP, Derdak S, Phipps RP: Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 1994, 152: 3606-3614.
93. Beller TC, Friend DS, Maekawa A, Lam BK, Austen KF, Kanaoka Y: Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci USA 2004, 101:3047-3052.
94. Brunning RD, McKenna RW, Rosai J, Parkin JL, Risdall R: Systemic mastocytosis. Extracutaneous manifestations. Am J Surg Pathol 1983, 7:425-438.
95. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985, 162: 163-2168.
96. 2 production by human synovial cells. J Clin Invest 1986, 77:645-648.
97. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino JV Jr, O'Connor MA: Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986, 163:1433-1450.
98. Tetlow LC, Woolley DE: Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995, 54:896-903.
99. Huttunen M, Naukkarinen A, Horsmanheimo M, Harvima IT: Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing. Arch Dermatol Res 2002, 294:324-330.
100. Kiener HP, Hofbauer R, Tohidast-Akrad M, Walchshofer S, Redlich K, Bitzan P, Kapiotis S, Steiner G, Smolen JS, Valent P: Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis. Arthritis Rheum 2000, 43:164-174.
101. Ceponis A, Konttinen YT, Takagi M, Xu JW, Sorsa T, Matucci-Cerinic M, Santavirta S, Bankl HC, Valent P: Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation. J Rheumatol 1998, 25:2304-2314.
102. Brannan CI, Lyman SD, Williams DE, Eisenman J, Anderson DM, Cosman D, Bedell MA, Jenkins NA, Copeland NG: Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci USA 1991, 88:4671-4674.
103. Kitamura Y, Go S: Decreased production of mast cells in Sl/Sld anemic mice. Blood 1979, 53:492-497.
104. 2. J Immunol 1987, 139:3431-3441.
105. Hogaboam C, Kunkel SL, Strieter RM, Taub DD, Lincoln P, Standiford TJ, Lukacs NW: Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J Immunol 1998, 160:6166-6171.
106. Sellge G, Lorentz A, Gebhardt T, Levi-Schaffer F, Bektas H, Manns MP, Schuppan D, Bischoff SC: Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor. J Immunol 2004, 172:260-267.
107. Koch AE: Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003, Suppl 2:60-67.
108. Gravallese, EM, Pettit AR, Lee R, Madore R, Manning C, Tsay A, Gaspar J, Goldring MB, Goldring SR, Oettgen P: Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis 2003, 62:100-107.
109. Hiromatsu Y, Toda S: Mast cells and angiogenesis. Microsc Res Tech 2003, 60:64-69.
110. Stevens RL, Somerville LL, Sewell D, Swafford JR, Caulfield JP, Levi-Schaffer F, Hubbard JR, Dayton ET: Serosal mast cells maintain their viability and promote the metabolism of cartilage proteoglycans when cocultured with chondrocytes. Arthritis Rheum 1992, 35:325-335.
111. Tetlow LC, Adlam DJ, Woolley DE: Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001, 44:585-594.
112. Taylor DJ, Yoffe JR, Brown DM, Woolley DE: Histamine stimulates prostaglandin E production by rheumatoid synovial cells and human articular chondrocytes in culture. Arthritis Rheum 1986, 29:160-165.
113. Walton KJ, Duncan JM, Deschamps P, Shaughnessy SG: Heparin acts synergistically with interleukin-11 to induce STAT3 activation and in vitro osteoclast formation. Blood 2002, 100:2530-2536.
114. Chowdhury MH, Hamada C, Dempster DW: Effects of heparin on osteoclast activity. J Bone Miner Res 1992, 7:771-777.
115. Scheven BA, Milne JS, Hunter I, Robins SP: Macrophage-inflammatory protein-1α regulates preosteoclast differentiation in vitro. Biochem, Biophys Res Commun 1999, 254:773-778.